XML 75 R63.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:        
Net income (loss) $ (41,064) $ (33,942) $ (671) $ (188,328)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:        
Equity in earnings of subsidiaries 0 0 0 0
Depreciation, depletion and amortization 132,289 111,948 384,246 356,885
Loss on extinguishment of debt 0 13,793 0 (4,865)
Loss on sale of properties     0 1,305
Impairment 139 382 6,021 3,967
Deferred income taxes     (470) (96,818)
Derivative instruments 54,310 (20,847) (52,297) 55,624
Equity-based compensation expenses     20,451 18,761
Deferred financing costs amortization and other     12,666 10,174
Working capital and other changes:        
Change in accounts receivable     (81,022) 11,349
Change in inventory     (235) 2,559
Change in prepaid expenses     823 1,168
Change in other current assets     276 (240)
Change in long-term inventory and other assets     (12,843) (148)
Change in accounts payable, interest payable and accrued liabilities     32,282 (41,991)
Change in other current liabilities     (10,490) (6,000)
Change in other liabilities     0 17
Net cash provided by operating activities     298,737 123,419
Cash flows from investing activities:        
Capital expenditures     (443,649) (340,314)
Proceeds from sale of properties     4,000 12,333
Costs related to sale of properties     0 (310)
Derivative settlements     (804) 115,576
Advances from joint interest partners     (2,502) 544
Net cash used in investing activities     (442,955) (212,171)
Cash flows from financing activities:        
Proceeds from revolving credit facility     764,000 835,000
Principal payments on revolving credit facility     (732,000) (778,000)
Repurchase of senior unsecured notes     0 (435,907)
Proceeds from issuance of senior unsecured convertible notes     0 300,000
Deferred financing costs     (96) (8,811)
Proceeds from sale of common stock     0 182,791
Purchases of treasury stock     (6,182) (2,275)
Investment in / capital contributions from subsidiaries     0 0
Other     (55) 0
Proceeds from sale of Oasis Midstream common units, net of offering costs     115,813 0
Net cash provided by financing activities     141,480 92,798
Increase (decrease) in cash and cash equivalents     (2,738) 4,046
Beginning of period     11,226 9,730
End of period 8,488 13,776 8,488 13,776
Intercompany Eliminations [Member]        
Cash flows from operating activities:        
Net income (loss) 11,994   (75,984) 110,454
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:        
Equity in earnings of subsidiaries (11,994) (1,140) 75,984 (110,454)
Depreciation, depletion and amortization 0 0 0 0
Loss on extinguishment of debt   0   0
Loss on sale of properties       0
Impairment 0 0 0 0
Deferred income taxes     0 0
Derivative instruments 0 0 0 0
Equity-based compensation expenses     0 0
Deferred financing costs amortization and other     0 0
Working capital and other changes:        
Change in accounts receivable     (103,778) 99,943
Change in inventory     0 0
Change in prepaid expenses     0 0
Change in other current assets     0 0
Change in long-term inventory and other assets     0 0
Change in accounts payable, interest payable and accrued liabilities     103,778 (99,943)
Change in other current liabilities     0 0
Change in other liabilities       0
Net cash provided by operating activities     0 0
Cash flows from investing activities:        
Capital expenditures     0 0
Proceeds from sale of properties     0 0
Costs related to sale of properties       0
Derivative settlements     0 0
Advances from joint interest partners     0 0
Net cash used in investing activities     0 0
Cash flows from financing activities:        
Proceeds from revolving credit facility     0 0
Principal payments on revolving credit facility     0 0
Repurchase of senior unsecured notes       0
Proceeds from issuance of senior unsecured convertible notes       0
Deferred financing costs     0 0
Proceeds from sale of common stock       0
Purchases of treasury stock     0 0
Investment in / capital contributions from subsidiaries     0 0
Other     0  
Proceeds from sale of Oasis Midstream common units, net of offering costs     0  
Net cash provided by financing activities     0 0
Increase (decrease) in cash and cash equivalents     0 0
Beginning of period     0 0
End of period 0 0 0 0
Parent/Issuer [Member]        
Cash flows from operating activities:        
Net income (loss) (41,214)   (821) (188,328)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:        
Equity in earnings of subsidiaries 13,599 1,140 (74,379) 110,454
Depreciation, depletion and amortization 0 0 0 0
Loss on extinguishment of debt   13,793   (4,865)
Loss on sale of properties       0
Impairment 0 0 0 0
Deferred income taxes     (44,923) (34,891)
Derivative instruments 0 0 0 0
Equity-based compensation expenses     19,740 18,195
Deferred financing costs amortization and other     11,399 5,371
Working capital and other changes:        
Change in accounts receivable     115,996 (85)
Change in inventory     0 0
Change in prepaid expenses     (190) (135)
Change in other current assets     0 0
Change in long-term inventory and other assets     0 100
Change in accounts payable, interest payable and accrued liabilities     (12,571) 70,285
Change in other current liabilities     0 0
Change in other liabilities       0
Net cash provided by operating activities     14,251 (23,899)
Cash flows from investing activities:        
Capital expenditures     0 0
Proceeds from sale of properties     0 0
Costs related to sale of properties       0
Derivative settlements     0 0
Advances from joint interest partners     0 0
Net cash used in investing activities     0 0
Cash flows from financing activities:        
Proceeds from revolving credit facility     0 0
Principal payments on revolving credit facility     0 0
Repurchase of senior unsecured notes       (435,907)
Proceeds from issuance of senior unsecured convertible notes       300,000
Deferred financing costs     0 (7,880)
Proceeds from sale of common stock       182,791
Purchases of treasury stock     (6,182) (2,275)
Investment in / capital contributions from subsidiaries     (8,002) (13,517)
Other     (55)  
Proceeds from sale of Oasis Midstream common units, net of offering costs     0  
Net cash provided by financing activities     (14,239) 23,212
Increase (decrease) in cash and cash equivalents     12 (687)
Beginning of period     166 777
End of period 178 90 178 90
Combined Guarantor Subsidiaries [Member]        
Cash flows from operating activities:        
Net income (loss) (13,449)   74,529 (110,454)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:        
Equity in earnings of subsidiaries (1,605) 0 (1,605) 0
Depreciation, depletion and amortization 132,035 111,948 383,992 356,885
Loss on extinguishment of debt   0   0
Loss on sale of properties       1,305
Impairment 139 382 6,021 3,967
Deferred income taxes     44,453 (61,927)
Derivative instruments 54,310 (20,847) (52,297) 55,624
Equity-based compensation expenses     711 566
Deferred financing costs amortization and other     1,260 4,803
Working capital and other changes:        
Change in accounts receivable     (87,610) (88,509)
Change in inventory     (235) 2,559
Change in prepaid expenses     1,013 1,303
Change in other current assets     276 (240)
Change in long-term inventory and other assets     (12,843) (248)
Change in accounts payable, interest payable and accrued liabilities     (62,542) (12,333)
Change in other current liabilities     (10,490) (6,000)
Change in other liabilities       17
Net cash provided by operating activities     284,633 147,318
Cash flows from investing activities:        
Capital expenditures     (443,649) (340,314)
Proceeds from sale of properties     4,000 12,333
Costs related to sale of properties       (310)
Derivative settlements     (804) 115,576
Advances from joint interest partners     (2,502) 544
Net cash used in investing activities     (442,955) (212,171)
Cash flows from financing activities:        
Proceeds from revolving credit facility     764,000 835,000
Principal payments on revolving credit facility     (732,000) (778,000)
Repurchase of senior unsecured notes       0
Proceeds from issuance of senior unsecured convertible notes       0
Deferred financing costs     1,858 (931)
Proceeds from sale of common stock       0
Purchases of treasury stock     0 0
Investment in / capital contributions from subsidiaries     121,714 13,517
Other     0  
Proceeds from sale of Oasis Midstream common units, net of offering costs     0  
Net cash provided by financing activities     155,572 69,586
Increase (decrease) in cash and cash equivalents     (2,750) 4,733
Beginning of period     11,060 8,953
End of period 8,310 $ 13,686 8,310 $ 13,686
Non-Guarantor Subsidiaries [Member]        
Cash flows from operating activities:        
Net income (loss) 1,605   1,605  
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by (used in) operating activities:        
Equity in earnings of subsidiaries 0   0  
Depreciation, depletion and amortization 254   254  
Impairment 0   0  
Deferred income taxes     0  
Derivative instruments 0   0  
Equity-based compensation expenses     0  
Deferred financing costs amortization and other     7  
Working capital and other changes:        
Change in accounts receivable     (5,630)  
Change in inventory     0  
Change in prepaid expenses     0  
Change in other current assets     0  
Change in long-term inventory and other assets     0  
Change in accounts payable, interest payable and accrued liabilities     3,617  
Change in other current liabilities     0  
Net cash provided by operating activities     (147)  
Cash flows from investing activities:        
Capital expenditures     0  
Proceeds from sale of properties     0  
Derivative settlements     0  
Advances from joint interest partners     0  
Net cash used in investing activities     0  
Cash flows from financing activities:        
Proceeds from revolving credit facility     0  
Principal payments on revolving credit facility     0  
Deferred financing costs     (1,954)  
Purchases of treasury stock     0  
Investment in / capital contributions from subsidiaries     (113,712)  
Other     0  
Proceeds from sale of Oasis Midstream common units, net of offering costs     115,813  
Net cash provided by financing activities     147  
Increase (decrease) in cash and cash equivalents     0  
Beginning of period     0  
End of period $ 0   $ 0